Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
- Conditions
- Breast Cancer
- Interventions
- Device: TomosynthesisDevice: Conventional
- Registration Number
- NCT01669148
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
The primary hypothesis to be tested is:
The detection of breast cancer will be increased with tomosynthesis (3D) imaging
- Detailed Description
The purpose of this study is to determine if: 1 the detection of breast cancer will be increased with conventional (2D) imaging plus tomosynthesis (3D) imaging, or 2. if the the detection of breast cancer will be increased with tomosynthesis (3D) imaging alone.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 496
- Female
- Any ethnic origin
- No contraindication for routine bilateral mammography
Potential subjects with any of the following will not be enrolled in the study:
-
Any contraindications to mammographic screening, including, but not limited to:
-
Significant existing breast trauma
-
Under the age of 30 at the time of consent
-
Breast Implants
-
Prior Surgeries
- Unable to understand and execute written informed consent
- Pregnant
- Lactating
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tomosynthesis alone Tomosynthesis tomosynthesis (3D) imaging alone first then conventional (2D) imaging plus tomosyntheis 1 month later. Conventional + Tomosynthesis Conventional conventional (2D) imaging plus tomosynthesis (3D) imaging first then tomosynthesis alone 1 month later. Conventional + Tomosynthesis Tomosynthesis conventional (2D) imaging plus tomosynthesis (3D) imaging first then tomosynthesis alone 1 month later.
- Primary Outcome Measures
Name Time Method Detection of Breast Cancer (Sensitivity) up to two years follow up for development of breast cancer Sensitivity is the number of true positives (TP) divided by the sum of TP and false negatives (FN):
Sensitivity = TP / (TP+FN)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
MGH
🇺🇸Boston, Massachusetts, United States